# Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers

> **NCT00436787** · PHASE2 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 21 (estimated)

## Conditions studied

- Venous Thrombosis
- Pulmonary Embolism

## Interventions

- **DRUG:** Fondaparinux Sodium

## Key facts

- **NCT ID:** NCT00436787
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2008-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00436787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00436787, "Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00436787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*